J&J uses web video, teacher outreach in UK ADHD effort

Share this article:
J&J uses web video, teacher outreach in UK ADHD effort
J&J uses web video, teacher outreach in UK ADHD effort

Johnson & Johnson's Janssen-Cilag launched an animated patient education video aimed at showing viewers the world from the perspective of a child with ADHD and urging parents to see a doctor about behavioral problems.

The film is part of an unbranded UK campaign including outreach to teachers and is featured on Livingwithadhd.co.uk. The film employs a technique called “rotoscoping,” in which real actors are filmed and converted into animations, and was developed through interviews with patients, parents, doctors and teachers. It visually depicts the child's attention drifting and explores the guilt that parents of children with ADHD often feel.

It's meant encourage parents to take the initial step of seeing a doctor about their child's behavioral problems – a step that research shows gives parents great satisfaction, the company said, either for relief that a diagnosis has been made or for reassurance at having spoken to a professional.

“It might be that certain teachers currently have children with ADHD in their classrooms but that haven't yet realized it or are struggling to cope,” said ADHD educational advisor Holly Evans in a release. “If improved understanding and knowledge about ADHD can filter down to at least a small proporation of the teaching population, it will make a big impact.”

The J&J unit makes Concerta XL for ADHD.

Share this article:

Email Newsletters

More in News

Eli Lilly and BI's Jardiance hits shelves

Eli Lilly and BI's Jardiance hits shelves

The new SGLT-2 inhibitor is on shelves less than a month after FDA approval.

PhRMA Urges Court to Reject Off-Label Promotion Case

PhRMA Urges Court to Reject Off-Label Promotion Case

The Pharmaceutical Research and Manufacturers of America (PhRMA) says a California federal court should dismiss a whistleblower's False Claims Act suit against three drug companies on First Amendment grounds

Five things for Pharma Marketers to know: Tuesday, August 26

Five things for Pharma Marketers to know: Tuesday, ...

Merck and Pfizer pursue new pembrolizumab research, black box warnings are linked to fewer court visits, and the WHO says it needs $430M to fight Ebola.